Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
10
×
fda
10
×
life sciences
national blog main
national top stories
boston blog main
boston top stories
clinical trials
san francisco blog main
san francisco top stories
national
new york blog main
new york top stories
san diego blog main
san diego top stories
europe top stories
abbvie
boston
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
europe blog main
raleigh-durham blog main
raleigh-durham top stories
roche
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
atlas ventures
cancer
ceo
commissioner
drug development
drug pricing
drugs
eli lilly
What
medicine
10
×
fda
drug
patients
big
bio
cells
friday
gain
health
loss
marketing
new
rest
roche
roundup
treatment
vote
weight
acquire
advance
ago
agreed
alkermes
alnylam
amgen
amgen’s
anemia
antipsychotic
approval
approve
approved
atrophy
awaits
benefits
billion
biological
biopharma
blood
body
Language
unset
Current search:
biotech
×
medicine
×
fda
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
@xconomy.com
6 years ago
Histogen Treatment for Female Hair Loss Cleared for Clinical Testing